Influence of Borane Reagent on Diastereoselectivity and Reaction Pathway
The choice of borane reagent in the hydroboration step exerts a decisive influence on the diastereoselectivity and overall outcome of the reductive aldol reaction leading to syn-hydroxy-vinyl carboxylic esters. Comparative studies using different hydroborating agents revealed distinct mechanistic pathways that result in divergent stereochemical products. When (Ipc)₂BH was employed, the reaction with ethyl allenecarboxylate (2) produced a mixture of intermediates—Z-(O)-8b, E-(O)-8b, and Z-(C)-7b—in a ratio of 2.3:0.05:1, as confirmed by ¹H NMR analysis. This mixture remained unchanged over time, indicating kinetic control and the absence of significant equilibration under standard conditions. Subsequent reaction with benzaldehyde yielded both syn-3a and anti-3a in approximately equal amounts (1:1 ratio), albeit with high enantioselectivity (80% ee).1,9-Diaminononane custom synthesis This outcome arises from the competing reactivity of two distinct intermediates: the dienolborinate Z-(O)-8b undergoes a syn-selective aldol reaction, while the allylborane Z-(C)-7b preferentially forms the anti-adduct.Famoxadone web
In contrast, when 9-BBN was used as the hydroborating agent, the reaction proceeded exclusively through a single pathway.PMID:34988770 ¹H NMR analysis showed that only Z-(C)-7c was formed, with no detectable Z-(O)-8c or E-(O)-8c. This observation is consistent with a low-energy 1,5-boratropic shift that rapidly converts the initial 1,4-adduct into the more stable allylborane species. The resulting Z-(C)-7c then reacts with aldehydes via an allylboration mechanism, producing the anti-hydroxy-vinyl carboxylic ester as the sole product in 90% yield. The high diastereoselectivity (>40:1 dr) and complete absence of syn-isomer confirm the dominance of this pathway under these conditions.
These contrasting results highlight a fundamental difference in the reactivity profiles of the two boranes. The bulky 10-TMS group in Soderquist’s borane (1R) sterically inhibits rearrangement, trapping the intermediate as Z-(O)-8a and enabling subsequent syn-selective aldol reactions. Conversely, 9-BBN lacks such steric protection, allowing rapid isomerization to the thermodynamically favored allylborane Z-(C)-7c, which leads to anti-selective addition.
This dichotomy presents a strategic opportunity: by selecting the appropriate borane reagent, one can access either the syn- or anti-diastereoisomer of the hydroxy-vinyl ester with high selectivity. While 1R enables enantioselective synthesis of the syn-isomer, 9-BBN offers a complementary route to the anti-isomer. These findings not only explain experimental observations but also open new avenues for stereocontrol in complex molecule synthesis. The ability to switch between diastereomers simply by changing the borane reagent underscores the versatility and precision of this methodology in asymmetric synthesis.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
The bradykinin-BDKRB1 axis has emerged as a critical signaling pathway in the progression of glioblastoma multiforme (GBM), linking inflammatory microenvironmental cues to aggressive tumor behavior. Bradykinin, a potent vasoactive peptide generated through activation of the kallikrein-kinin system (KKS), accumulates in GBM tissues under conditions of hypoxia, inflammation, and blood-tumor barrier disruption. While BDKRB2 is constitutively expressed, BDKRB1 is inducible and upregulated in response to pathological stimuli, making it a key sensor of tumor stress. In human glioblastoma cells, exposure to bradykinin leads to selective upregulation of BDKRB1 expression, triggering intracellular calcium influx that initiates a cascade of downstream events culminating in enhanced migration, invasion, and survival.
This signaling cascade proceeds through a Ca²⁺-MEK1-ERK1/2-NF-κB pathway. Upon binding to BDKRB1, bradykinin activates G-protein-coupled receptor signaling, leading to phospholipase C activation and subsequent IP₃-mediated release of Ca²⁺ from endoplasmic reticulum stores. The resulting increase in cytosolic Ca²⁺ levels serves as a second messenger that activates protein kinase C (PKC) and calmodulin-dependent kinases, which in turn phosphorylate MEK1. Activated MEK1 then stimulates ERK1/2, promoting nuclear translocation of transcription factors such as NF-κB. Once in the nucleus, NF-κB binds to specific DNA sequences in the promoter regions of target genes, including aquaporin-4 (AQP4), thereby amplifying pro-invasive signals.
Importantly, inhibition of BDKRB1 using small interfering RNA (siRNA) or selective antagonists abrogates these effects. Knockdown of BDKRB1 reduces Ca²⁺ mobilization, suppresses MEK1/ERK1/2 phosphorylation, prevents NF-κB activation, and diminishes AQP4 expression. These molecular changes are accompanied by significant reductions in both wound-healing capacity and Matrigel-based invasion, confirming the functional relevance of this axis in driving glioblastoma motility.Tetrathiafulvalene Purity & Documentation
Clinically, targeting the bradykinin-BDKRB1 axis holds substantial therapeutic promise.Anti-Amyloid Beta Antibody supplier Selective BDKRB1 antagonists have demonstrated antiproliferative, anti-inflammatory, and anti-migratory properties in preclinical models without disrupting homeostatic functions mediated by BDKRB2.PMID:35246262 Unlike broad-spectrum inhibitors, BDKRB1 antagonism may offer greater specificity with fewer off-target effects, particularly given its limited expression in normal tissues outside the context of injury or disease. Furthermore, combining BDKRB1 blockade with standard therapies such as temozolomide or radiation could enhance efficacy by reducing tumor invasiveness and overcoming resistance mechanisms linked to microenvironmental signaling.
Recent studies also suggest that modulating this axis can improve drug delivery. Since bradykinin increases blood-tumor barrier permeability via BDKRB1 activation, pharmacological agents that transiently activate this receptor—such as RMP-7—have been tested in clinical trials to facilitate the entry of chemotherapeutics like carboplatin into brain tumors. However, sustained activation promotes tumor progression; thus, precise temporal control is essential. Future strategies may involve dual-use compounds that first open the barrier for drug delivery and then block the receptor to prevent pro-invasive signaling.
In summary, the bradykinin-BDKRB1 axis represents a master regulator of glioblastoma malignancy, integrating environmental stress signals into cellular responses that drive invasion and survival. Its well-defined molecular pathway, tumor-specific activation, and potential for targeted intervention make it an ideal candidate for next-generation GBM therapies. Ongoing research aims to develop optimized BDKRB1-directed therapeutics and evaluate their efficacy in orthotopic models, paving the way for clinical translation and improved outcomes for patients with this devastating disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
The apolipoprotein E (APOE) genotype is a major determinant of Alzheimer’s disease susceptibility, with APOE4 increasing risk while APOE3 confers relative protection. This study explored the functional impact of microglial APOE isoforms on amyloid pathology and neuroinflammatory responses using a bone marrow transplantation (BMT) approach in APPswe/PS1DE9 mice. Lethally irradiated 5-month-old transgenic mice received BMT from either APOE3/3 or APOE4/4 donor mice expressing green fluorescent protein (GFP). Eight months post-transplantation, recipients of APOE3/3 bone marrow exhibited significantly greater engraftment of GFP+ microglia in the cerebral cortex and hippocampus compared to APOE4/4 recipients—55.2% versus 39.3% in the cortex and 63.0% versus 44.9% in the hippocampus—indicating a survival or migration advantage for APOE3-expressing microglia. Despite similar total microglial density, this enhanced engraftment correlated with increased brain apoE levels: APOE3/3 recipients had 45% higher cortical and 40% higher hippocampal apoE concentrations than APOE4/4 recipients. Behavioral testing revealed that APOE3/3 BMT mice displayed improved spatial working memory in the Barnes maze, with shorter escape latency, reduced distance traveled, and fewer errors during reversal learning, whereas APOE4/4 recipients showed persistent cognitive deficits. Immunohistochemical analysis demonstrated a significant reduction in amyloid plaque burden in APOE3/3 recipients, particularly in the hippocampus, with lower plaque area, frequency, and mean size. Confocal imaging confirmed increased association of GFP+ microglia with plaques in APOE3/3 mice, suggesting enhanced phagocytic engagement. Biochemical analysis revealed no difference in Tris-HCl-soluble Ab40 or Ab42, but guanidine-soluble Ab40 was markedly reduced in both cortex and hippocampus of APOE3/3 recipients, indicating more efficient clearance of aggregated amyloid.21-Desacetyldeflazacort-d5 In Vitro Gene expression profiling showed downregulation of proinflammatory mediators TNF-α and MIF, and upregulation of anti-inflammatory IL-10 in the cerebral cortex of APOE3/3 recipients.Phospho-p27 Kip 1 Antibody Technical Information No differences were observed in other cytokines or chemokine receptors such as CCR2, CX3CR1, or C5aR.PMID:35148014 Flow cytometry confirmed comparable surface expression of key immune markers across genotypes, ruling out intrinsic receptor-level disparities. These findings demonstrate that APOE3-expressing microglia are more effective in reducing amyloid accumulation, modulating neuroinflammation, and preserving cognitive function in a mouse model of Alzheimer’s disease. The results highlight the critical role of microglial APOE isoform in determining disease outcomes and support the therapeutic potential of targeting APOE3-associated microglial functions to combat neurodegeneration.
The American Journal of Pathology
ajp.amjpathol.org
Volume 183, Issue 3, September 2013
Pages 905–917MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
Metabolic syndrome (MetSyn) is a growing public health challenge in Puerto Rico, where prevalence rates exceed those of most U.S. racial and ethnic groups. Given the strong association between cigarette smoking and key components of MetSyn—particularly dyslipidemia and insulin resistance—targeted tobacco control efforts are essential to reducing disease burden. This study underscores the need for comprehensive, culturally tailored interventions that go beyond simple cessation support to address the root causes of smoking initiation and relapse within Puerto Rican communities. Effective strategies must integrate prevention, early intervention, and long-term follow-up across healthcare systems, schools, workplaces, and community organizations.
Prevention programs should prioritize youth and young adults, who are most vulnerable to smoking initiation. Culturally relevant messaging that incorporates local values, language, and social norms can enhance engagement and effectiveness. School-based curricula emphasizing the metabolic consequences of smoking—such as increased risk of heart disease, diabetes, and weight gain after quitting—can foster informed decision-making. Workplace wellness initiatives and community health campaigns led by trusted local figures can further amplify reach and impact. Additionally, policies such as smoke-free environments, high tobacco taxes, and restrictions on advertising have proven effective in reducing smoking rates across populations.
For current smokers, evidence-based cessation programs must be accessible, affordable, and integrated into routine medical care. Pharmacological treatments like nicotine replacement therapy and varenicline, combined with behavioral counseling, significantly increase quit success rates. However, these services are often underutilized due to stigma, cost, or lack of awareness. Implementing systematic screening for tobacco use during primary care visits and linking patients to specialized cessation resources can improve outcomes. Post-cessation support is equally critical: monitoring for weight gain, providing nutritional guidance, and encouraging physical activity can mitigate the rise in MetSyn risk observed after quitting.
Longitudinal studies suggest that metabolic risks associated with smoking may persist even years after cessation, particularly among heavy smokers.Avelumab site Therefore, ongoing health surveillance and lifestyle coaching are necessary to prevent the development of chronic conditions.2-(2-Bromoethyl)-1,3-dioxane medchemexpress Healthcare providers should routinely assess MetSyn components—waist circumference, lipid profile, blood pressure, and glucose levels—in former smokers, enabling early detection and intervention.PMID:35152872
Ultimately, reducing the burden of MetSyn in Puerto Rico requires a systemic shift toward proactive, population-level tobacco control. By combining prevention, cessation, and post-cessation care within a unified public health framework, Puerto Rican communities can achieve meaningful reductions in metabolic disease and improve long-term health outcomes. System-wide integration of smoking identification and evidence-based treatment into standard clinical practice will ensure that every individual at risk receives timely, effective support.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, resulting from the t(9;22)(q34;q11) translocation that generates the BCR-ABL1 fusion oncogene. While the classic translocation accounts for the majority of cases, approximately 2–10% exhibit variant forms involving additional chromosomes. These complex rearrangements often obscure the classical karyotypic marker and require advanced molecular techniques for detection. We report a novel case of CML with a complex variant translocation involving chromosomes 9, 12, and 22, where the breakpoint on der(22) lies within the BCR gene, and the fusion gene is formed through insertion of the 22q11 segment into chromosome 9 via a reciprocal event with chromosome 12.
Cytogenetic analysis revealed a balanced t(12;22)(q13;q11.2) without apparent involvement of chromosome 9. However, RT-qPCR detected a major BCR-ABL1 transcript (P210) at a ratio of 14.95% on the International Scale, indicating active disease. FISH using a dual-fusion probe confirmed the presence of a single BCR-ABL1 fusion signal on der(22), while green signals were observed on chromosome 12, consistent with the t(12;22) breakpoint distal to BCR. Sub-telomeric 9qter FISH showed normal signals, ruling out large deletions at the telomere. Karyotype interpretation revealed a complex rearrangement: 46,XX,der(9)del(9)(q34q34)ins(22;9)(q11.Cofetuzumab pelidotin supplier 2;q34q34),der(12)t(12;22)(q13;q11.2),der(22)ins(22;9)t(12;22)[22].3-Methylquinoline manufacturer This configuration indicates that the BCR-ABL1 fusion arose through the insertion of the 22q11 segment into chromosome 9, facilitated by a reciprocal translocation between chromosomes 12 and 22.
The mechanism behind this rare chromosomal rearrangement remains speculative but can be inferred from genomic architecture.PMID:35080656 Breakpoints in variant Philadelphia translocations are nonrandom, showing strong clustering in regions enriched for CG dinucleotides, Alu repeats, LINE elements, and microRNA genes—features associated with recombination hotspots. The 12q13 region involved in this case has been previously linked to complex Philadelphia translocations and fragile site FRA12A, which results from expanded CGG repeats in the 5′ untranslated region of the DIP2B gene (OMIM 611379). Such repetitive sequences promote DNA instability, increasing susceptibility to double-strand breaks and erroneous repair.
We hypothesize that a one-step mechanism involving four simultaneous breaks occurred: two breaks on chromosomes 12 and 22, and two on chromosomes 9 and 22. This would allow for the formation of der(9) with deletion of q34, der(12) with translocation of q13, and der(22) carrying both the BCR-ABL1 fusion and the t(12;22) breakpoint. The absence of additional clonal abnormalities at diagnosis and the presence of only one breakpoint on der(22) support this model over sequential translocations. Furthermore, the fact that the fusion gene is located within the BCR sequence suggests that the break occurred within the breakpoint cluster region, a known hotspot for recombination.
This case represents the first reported instance of a three-way translocation involving chromosomes 9, 12, and 22 in CML. It underscores the importance of integrating molecular diagnostics—especially FISH and RT-PCR—in detecting cryptic fusion genes when conventional cytogenetics fails to reveal the Philadelphia chromosome. The patient achieved sustained hematologic and molecular remission with imatinib therapy, despite the presence of a der(9) deletion and later trisomy 8/9 clones. This outcome challenges the notion that complex variants uniformly confer poor prognosis and highlights the potential for favorable responses even in structurally complex rearrangements.
Future studies should focus on identifying recurrent genomic motifs that predispose to such events and assess whether specific breakpoints correlate with treatment resistance or disease progression. Understanding these mechanisms may lead to improved risk stratification and targeted monitoring strategies in patients with variant Philadelphia translocations.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
The progressive loss of neurotrophic support in Alzheimer’s disease (AD) is closely linked to impaired axonal transport and disrupted signaling from the synapse to the nucleus. A key component of this dysfunction involves the retrograde trafficking of brain-derived neurotrophic factor (BDNF) and its receptor, TrkB. Our previous findings demonstrated that amyloid-β (Aβ) oligomers impair BDNF/TrkB retrograde transport by reducing endosomal vesicle velocities, leading to diminished activation of downstream effectors such as ERK5 and CREB-dependent gene expression. However, the precise molecular mechanism underlying this deficit remained unclear.
To explore potential rescue strategies, we investigated whether increasing cellular levels of ubiquitin C-terminal hydrolase L1 (UCH-L1), a critical deubiquitinating enzyme involved in maintaining ubiquitin homeostasis, could reverse Aβ-induced trafficking deficits. UCH-L1 plays a vital role in recycling ubiquitin from degraded proteins, thereby preserving the free ubiquitin pool necessary for proper endosomal sorting and signal transduction.
We employed a transducible TAT-HA-UCH-L1 fusion protein—a cell-penetrating construct derived from the HIV transactivator protein (TAT) fused with hemagglutinin (HA) tag and full-length UCH-L1. This strategy allowed efficient delivery of functional UCH-L1 into primary rat hippocampal neurons cultured in microfluidic devices. Neurons were treated with Aβ oligomers (1 μM) at 7 days in vitro (DIV), followed by transduction with TAT-HA-UCH-L1 (20 nM) or vehicle control.
Time-lapse imaging revealed that in the presence of Aβ, the average velocity of BDNF-GFP-containing endosomes was significantly reduced compared to controls. However, when UCH-L1 was introduced via TAT transduction, the velocity of these vesicles was restored to near-normal levels.CYP7A1 Antibody Biological Activity Quantitative analysis showed that Aβ alone caused a 60.Ascorbyl palmitate Epigenetic Reader Domain 3% decrease in somal BDNF-GFP accumulation—indicative of impaired retrograde transport—compared to vehicle-treated neurons.PMID:34861663 In contrast, neurons receiving TAT-HA-UCH-L1 exhibited a 92.6% recovery of BDNF-GFP levels in the soma under Aβ exposure. Most notably, when both Aβ and UCH-L1 were present, retrograde transport was rescued to 86.3% of control levels, confirming a significant reversal of Aβ-induced deficits (*p* < 0.04). Immunocytochemical analysis further confirmed that UCH-L1 overexpression restored p-ERK5 activation in the nucleus following axonal BDNF stimulation. Western blotting validated this result, showing increased phosphorylation of ERK5 normalized to total ERK5 in the somal compartment after UCH-L1 treatment. Similarly, CREB-dependent gene expression, assessed using a CRE-GFP reporter construct, was significantly enhanced in UCH-L1-treated neurons exposed to Aβ, indicating restoration of transcriptional activity. These results demonstrate that elevating intracellular UCH-L1 levels can effectively counteract the detrimental effects of Aβ on BDNF/TrkB retrograde signaling. The rescue occurs despite continued Aβ exposure, suggesting that UCH-L1 acts downstream of Aβ binding and functions to restore ubiquitin availability and endosomal function. Our findings are consistent with the hypothesis that Aβ impairs neurotrophin signaling not by directly blocking receptor activity, but by disrupting the ubiquitin system. By restoring UCH-L1 function, the endosomal sorting machinery regains its capacity to traffic TrkB complexes efficiently along axons. This highlights UCH-L1 as a critical node in the pathway linking Aβ toxicity to synaptic failure. In conclusion, enhancing UCH-L1 activity represents a promising therapeutic approach to mitigate Aβ-induced axonal transport deficits in AD. Targeting ubiquitin homeostasis may offer a novel strategy to preserve neurotrophic signaling, support synaptic plasticity, and ultimately slow or reverse cognitive decline in Alzheimer’s disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
**Background**
The human gut microbiota produces a variety of metabolites that play critical roles in maintaining physiological homeostasis and modulating cellular functions. Among these, heterocyclic compounds derived from the metabolism of aromatic amino acids are of particular interest due to their ability to interact with systemic receptors. The aryl hydrocarbon receptor (AhR) and p38 mitogen-activated protein kinase (p38) are key signaling molecules involved in regulating inflammation, cell survival, and tissue remodeling. Dysregulation of these pathways is often linked to intestinal epithelial damage and vascular dysfunction. Understanding the impact of microbial metabolites on these pathways is essential for developing therapeutic strategies for gastrointestinal and cardiovascular diseases. In this context, we will introduce a human endogenous metabolite – Skatole.
**Definition**
Skatole (3-methylindole) is a heterocyclic compound and microbial metabolite that acts as an activator of the aryl hydrocarbon receptor (AhR) and p38.
**In Vitro Studies**
According to the Skatole description, this compound is naturally found in the feces of vertebrates and certain plants, and it is produced by intestinal bacteria. In terms of Skatole biological activity, in vitro studies have demonstrated that Skatole (0-1000 μM; 0-72 h) induces apoptosis in intestinal epithelial cells in a time- and dose-dependent manner. Specifically, treatment with Skatole (1000 μM) significantly activates AhR after 48 hours and p38 after 30 minutes. Beyond the intestinal epithelium, Skatole also influences vascular smooth muscle cells (VSMCs). Research indicates that Skatole (10 μM; 24 h) significantly reverses the suppressive effects of Irisin on Ang II-evoked proliferation, migration, and phenotypic transformation in VSMCs. These findings highlight the dual role of Skatole in modulating both epithelial apoptosis and vascular remodeling. In conclusion, Skatole is a potent microbial metabolite that regulates cellular functions through the activation of AhR and p38 signaling pathways.
Keywords
Skatole, 83-34-1, 3-Methylindole, 3-Methyl-1H-indole, Aryl Hydrocarbon Receptor, p38 MAPK, Endogenous Metabolite, Apoptosis, AhR, aryl hydrocarbon receptors, p38, intestinal bacteria, Inhibitor, inhibitor, inhibit
References
[1] Kurata K, et al. Skatole regulates intestinal epithelial cellular functions through activating aryl hydrocarbon receptors and p38. Biochem Biophys Res Commun. 2019 Mar 19;510(4):649-655.
[2] Zgarbová E, et al. Skatole: A thin red line between its benefits and toxicity. Biochimie. 2023 May;208:1-12.
[3] Li RL, et al. Irisin attenuates vascular remodeling in hypertensive mice induced by Ang II by suppressing Ca2+-dependent endoplasmic reticulum stress in VSMCs. Int J Biol Sci. 2024 Jan 1;20(2):680-700.
The regulation of systemic acquired resistance (SAR) in Arabidopsis relies on a precisely orchestrated network of protein-protein interactions centered around the NPR1 transcriptional regulator. Among the key modulators of NPR1 activity are the NIM1-INTERACTING (NIMIN) proteins, which collectively fine-tune defense gene expression through distinct and non-redundant mechanisms. Our study reveals that NIMIN1, NIMIN2, and NIMIN3 form functionally specialized complexes with NPR1, each contributing to a different phase of the immune response via unique structural and biochemical properties.
Structural analysis shows that while NIMIN1 and NIMIN2 bind to the C-terminal third of NPR1 through a conserved motif, they do so with divergent functional outcomes. Despite sharing similar interaction domains, these proteins exhibit opposing effects: NIMIN1 acts as a potent repressor of PR-1 gene activation, whereas NIMIN2 does not suppress transcription despite its ability to engage NPR1. This functional dichotomy is further underscored by yeast three-hybrid assays, which demonstrate that NIMIN1 and NIMIN2 cannot simultaneously bind NPR1. Instead, their binding is mutually exclusive, indicating competition for a shared site within the NPR1 C-terminus. Moreover, the presence of NIMIN3 disrupts complex formation between NPR1 and both NIMIN1 and NIMIN2, suggesting that NIMIN3 exerts a dominant regulatory influence over the entire complex.Anti-Rabbit IgG for IP Protocol
Further investigation into the molecular basis of this differential behavior reveals that SA sensitivity varies between the NIMIN-NPR1 complexes. While binary interactions between NPR1 and NIMIN1 are disrupted by SA at low concentrations (IC50 ≈ 20 µM), ternary complexes containing NIMIN2 and TGA transcription factors remain stable even in the presence of SA.2-Chloroterephthalic acid custom synthesis In contrast, complexes involving NIMIN1 are highly sensitive to SA, leading to dissociation. This differential sensitivity implies that NIMIN1 and NIMIN2 induce structurally distinct conformations in NPR1, altering its ability to recruit downstream transcriptional machinery.
Functional assays in Nicotiana benthamiana confirm these biochemical findings. Transient expression of NIMIN1 strongly inhibits SA-induced PR-1a promoter activity, whereas NIMIN2 has no significant effect. The EDF motif present in NIMIN1 and NIMIN3—absent in NIMIN2—is implicated in repression, though its role remains partially unresolved due to technical challenges in protein detection.PMID:35218517 Nonetheless, the conservation of this motif across species, including rice NRR, suggests a broader functional relevance in plant immunity.
These results paint a clear picture: the NIMIN proteins do not act uniformly but instead form a dynamic hierarchy of regulatory complexes. NIMIN3 provides constitutive repression, NIMIN2 initiates signal propagation by displacing NIMIN3, and NIMIN1 imposes a transient brake on late-stage activation. This sequential assembly and disassembly of complexes allow NPR1 to interpret fluctuating SA levels as a gradient of threat intensity, enabling plants to make precise biological decisions. Thus, the NIMIN-NPR1 interface functions not merely as a switch but as a molecular timer and integrator, ensuring that defense genes are activated only when the pathogen threat is unequivocal and sustained.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
**Background**
Adenoviruses are significant pathogens capable of causing a wide range of infections, including respiratory tract infections, conjunctivitis, and more severe systemic diseases in immunocompromised individuals. Ocular adenovirus infections, in particular, can lead to severe inflammation and potential vision loss, necessitating the development of effective topical antiviral therapies. Finding agents that can inhibit viral replication without inducing ocular toxicity is a primary goal in ophthalmic research. In this context, we will introduce a human endogenous metabolite with antiviral properties – Picolinic acid.
**Definition**
Picolinic acid is a human endogenous metabolite that acts as a topical antiviral agent. According to the Picolinic acid technical information, it is used to inhibit adenovirus replication, particularly in ocular models.
**In Vitro and In Vivo Studies**
The Picolinic acid biological activity has been evaluated across different biological systems. In vitro studies focusing on anti-inflammatory properties demonstrated that Picolinic acid exhibited inhibitory activity against human neutrophils, specifically inhibiting PMA-induced superoxide production with an IC50 value > 406 μM.
Regarding Picolinic acid in vivo efficacy, research was conducted using the Ad5/NZW rabbit ocular model. The study found that topical applications of 1.5% PCL, 0.8% PCL, 0.369% PCL (pH7), 0.369% PCL (pH4), and 0.5% CDV were significantly more effective than the control group in reducing the duration of adenovirus shedding and the number of Ad positive cultures per total from days 1 to 14. Furthermore, there appeared to be a trend toward concentration-dependent efficacy regarding the duration of viral shedding. Importantly, no apparent ocular toxicity was associated with the concentrations of Picolinic acid used in these models. In conclusion, Picolinic acid is a promising topical antiviral agent that inhibits adenovirus replication in rabbit ocular models.
Keywords
Picolinic acid, 98-98-6, PCL 016, PCL016, PCL-016, MOFs, Endogenous Metabolite, Virus Protease, Metal-Organic Frameworks, Inhibitor, inhibitor, inhibit
References
The proposed spectrophotometric methods were rigorously validated according to ICH guidelines to ensure accuracy, precision, linearity, sensitivity, robustness, and ruggedness. Calibration curves were constructed over defined concentration ranges: 1.0–30 µg mL⁻¹ for GMF, 1.0–20 µg mL⁻¹ for MXF, and 2.0–24 µg mL⁻¹ for ENF. All plots exhibited excellent linearity with correlation coefficients (r) exceeding 0.999, confirming adherence to Beer’s law. Apparent molar absorptivities ranged from 1.198 × 10⁴ to 4.1976 × 10⁴ L mol⁻¹ cm⁻¹, indicating high sensitivity. Limits of detection (LOD) and quantitation (LOQ) were calculated using standard equations: LOD = 3σ/S and LOQ = 10σ/S, where σ is the standard deviation of the blank and S is the slope of the calibration curve. For GMF, LOD values varied between 0.23 and 0.87 µg mL⁻¹ depending on the dye used; MXF ranged from 0.21 to 0.41 µg mL⁻¹; ENF showed LODs of 0.48 and 0.51 µg mL⁻¹ for BCG and BTB, respectively. LOQ values were also within acceptable limits, confirming the method’s suitability for trace analysis. Precision was assessed through intraday and interday studies involving six replicate determinations at four different concentrations. Relative standard deviation (RSD%) values remained below 1.2% across all drugs and reagents, demonstrating excellent repeatability. Accuracy was evaluated via percentage recovery and relative error (RE%), with results consistently ranging from 99.5-Methoxyisophthalic acid Purity & Documentation 3% to 100.Desmethylastemizole Purity 6%, indicating negligible bias.PMID:34985825 Robustness testing revealed no significant changes in absorbance when minor variations were introduced in pH, reagent volume, shaking time, or wavelength. Ruggedness was confirmed by comparing results obtained by two analysts using different instruments on separate days, yielding comparable RSD% values and no statistically significant differences (p > 0.05). The absence of interference from common excipients such as lactose, starch, sucrose, sodium chloride, talc, magnesium stearate, and titanium dioxide further confirms the selectivity of the methods. These comprehensive validation parameters confirm that the developed techniques are reliable, precise, sensitive, and suitable for routine quality control in pharmaceutical laboratories.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com